| Miss Nancy Irene Resi, FNP | |
|
28 Park Ave, Williston, VT 05495-9701 | |
| (802) 878-1008 | |
| Not Available |
| Full Name | Miss Nancy Irene Resi |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 25 Years |
| Location | 28 Park Ave, Williston, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134144124 | NPI | - | NPPES |
| ONP1991 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 10100101144 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Vermont Medical Center Inc | 3779491071 | 994 |
News Archive
Despite advances in treatment, people with a heart attack who survive the first hit and get to a hospital remain in danger.
The University of Maryland School of Medicine has been awarded a three-year, $2.47 million grant from the National Institute of Allergy and Infectious Diseases to develop a vaccine to protect against Shigella and Enterotoxigenic Escherichia coli (ETEC), pathogens which are among the leading causes of diarrheal diseases in young children in developing countries and a common cause of "traveler's diarrhea" among travelers to these countries.
Health innovation. Things are looking good in terms of the number of participants at the 2017 WHINN - Week and Health and Innovation knowledge festival.
Cancer Research Technology, the commercial arm of Cancer Research UK, and Paris-based venture capital firm, Kurma Life Sciences Partners (Kurma), have launched a spin-out company, BliNK Therapeutics Ltd, to generate monoclonal antibodies using a novel platform.
› Verified 1 days ago
| Entity Name | University Of Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
Despite advances in treatment, people with a heart attack who survive the first hit and get to a hospital remain in danger.
The University of Maryland School of Medicine has been awarded a three-year, $2.47 million grant from the National Institute of Allergy and Infectious Diseases to develop a vaccine to protect against Shigella and Enterotoxigenic Escherichia coli (ETEC), pathogens which are among the leading causes of diarrheal diseases in young children in developing countries and a common cause of "traveler's diarrhea" among travelers to these countries.
Health innovation. Things are looking good in terms of the number of participants at the 2017 WHINN - Week and Health and Innovation knowledge festival.
Cancer Research Technology, the commercial arm of Cancer Research UK, and Paris-based venture capital firm, Kurma Life Sciences Partners (Kurma), have launched a spin-out company, BliNK Therapeutics Ltd, to generate monoclonal antibodies using a novel platform.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Nancy Irene Resi, FNP 28 Park Ave, Williston, VT 05495-9701 Ph: (802) 878-1008 | Miss Nancy Irene Resi, FNP 28 Park Ave, Williston, VT 05495-9701 Ph: (802) 878-1008 |
News Archive
Despite advances in treatment, people with a heart attack who survive the first hit and get to a hospital remain in danger.
The University of Maryland School of Medicine has been awarded a three-year, $2.47 million grant from the National Institute of Allergy and Infectious Diseases to develop a vaccine to protect against Shigella and Enterotoxigenic Escherichia coli (ETEC), pathogens which are among the leading causes of diarrheal diseases in young children in developing countries and a common cause of "traveler's diarrhea" among travelers to these countries.
Health innovation. Things are looking good in terms of the number of participants at the 2017 WHINN - Week and Health and Innovation knowledge festival.
Cancer Research Technology, the commercial arm of Cancer Research UK, and Paris-based venture capital firm, Kurma Life Sciences Partners (Kurma), have launched a spin-out company, BliNK Therapeutics Ltd, to generate monoclonal antibodies using a novel platform.
› Verified 1 days ago
Mr. Scott A Paluska, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 28 Park Ave, Williston, VT 05495 Phone: 802-878-1008 Fax: 802-872-2679 | |
Dr. Rebecca Lynne Joyce, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 28 Park Ave, Williston, VT 05495 Phone: 802-878-1008 Fax: 802-872-2679 | |
Adriane Cross Trout, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 586 Oak Hill Rd, Williston, VT 05495 Phone: 802-878-8131 Fax: 802-879-6853 | |
Pamela Jane Dawson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 586 Oak Hill Rd, Williston, VT 05495 Phone: 802-878-8131 Fax: 802-879-6853 | |
Dr. David Nicholas Simcoe, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 586 Oak Hill Rd, Williston, VT 05495 Phone: 802-878-8131 Fax: 802-879-6853 | |
Stephen E Mann, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 586 Oak Hill, Williston, VT 05495 Phone: 802-878-8131 |